| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.29 | 0.08 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |